From: Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years
Tumor entity | Total | |||||||
---|---|---|---|---|---|---|---|---|
ALT | DLS | MLS | PLS | LSM | ||||
LR yes/no | Yes | Number of patients | 6 | 10 | 8 | 4 | 0 | 28 |
% of Tumor Entity | 11,5% | 47,6% | 21,6% | 36,4% | 0,0% | 23,0% | ||
No | Number of patients | 46 | 11 | 29 | 7 | 1 | 94 | |
% of Tumor Entity | 88,5% | 52,4% | 78,4% | 63,6% | 100,0% | 77,0% | ||
Total | Number of patients | 52 | 21 | 37 | 11 | 1 | 122 | |
% of Tumor Entity | 100,0% | 100,0% | 100,0% | 100,0% | 100,0% | 100,0% |